Skip to Content

Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes

Ângela Mesquita, PhD student, University of Bergen, Norway, presents in this MEDtalk from EHA 2024 a new model for predicting treatment efficacy for patients with Myelodysplastic syndromes. This new model may be a better predictor of treatment efficacy as it will integrate the critical role of the microenvironment.

Ângela Mesquita

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top